---
title: "Canakinumab - Tnf Receptor-Associated Periodic Fever Syndrome (Traps)"
sidebar: mydoc_sidebar
permalink: db06168-mesh-c536657-1.html
toc: false 
---


Path ID: `DB06168_MESH_C536657_1`
{% include image.html url="images/db06168-mesh-c536657-1.png" file="db06168-mesh-c536657-1.png" alt="db06168-mesh-c536657-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C541220">MESH:C541220 </a> | Canakinumab | Drug |
| <a href="https://identifiers.org/UniProt:P01584">UniProt:P01584 </a> | Interleukin-1 beta | Protein |
| <a href="https://identifiers.org/HP:0001945">HP:0001945 </a> | Fever | PhenotypicFeature |
| <a href="https://identifiers.org/HP:0002829">HP:0002829 </a> | Arthralgia | PhenotypicFeature |
| <a href="https://identifiers.org/GO:0006954">GO:0006954 </a> | Inflammatory response | BiologicalProcess |
| <a href="https://identifiers.org/MESH:C536657">MESH:C536657 </a> | TNF receptor-associated periodic fever syndrome (TRAPS) | Drug |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Canakinumab | DECREASES ACTIVITY OF | Interleukin-1 Beta |
| Interleukin-1 Beta | POSITIVELY REGULATES | Fever |
| Interleukin-1 Beta | POSITIVELY REGULATES | Inflammatory Response |
| Fever | MANIFESTATION OF | Tnf Receptor-Associated Periodic Fever Syndrome (Traps) |
| Inflammatory Response | HAS PHENOTYPE | Arthralgia |
| Arthralgia | MANIFESTATION OF | Tnf Receptor-Associated Periodic Fever Syndrome (Traps) |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB06168](https://go.drugbank.com/drugs/DB06168)
  - [https://en.wikipedia.org/wiki/TNF_receptor_associated_periodic_syndrome](https://en.wikipedia.org/wiki/TNF_receptor_associated_periodic_syndrome)
